75.19
                                            Schlusskurs vom Vortag:
              $77.16
            Offen:
              $76.78
            24-Stunden-Volumen:
                664.80K
            Relative Volume:
              0.59
            Marktkapitalisierung:
                $3.19B
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-63.78M
            KGV:
              -28.06
            EPS:
                -2.68
            Netto-Cashflow:
                $-53.91M
            1W Leistung:
              -2.99%
            1M Leistung:
              +48.86%
            6M Leistung:
                +589.82%
            1J Leistung:
              +403.62%
            Celcuity Inc Stock (CELC) Company Profile
Firmenname
                  
                      Celcuity Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      763-392-0767
                    
                Adresse
                  
                      16305 36TH AVENUE N, MINNEAPOLIS, MN
                    
                Vergleichen Sie CELC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CELC
                            
                             
                        Celcuity Inc 
                           | 
                    75.19 | 3.27B | 0 | -63.78M | -53.91M | -2.68 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-09-22 | Eingeleitet | Guggenheim | Buy | 
| 2025-07-01 | Fortgesetzt | Stifel | Buy | 
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform | 
| 2024-02-22 | Eingeleitet | Stifel | Buy | 
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy | 
| 2021-10-08 | Eingeleitet | Canaccord Genuity | Buy | 
| 2021-09-07 | Eingeleitet | Jefferies | Buy | 
| 2021-07-29 | Eingeleitet | Cowen | Outperform | 
| 2021-07-27 | Eingeleitet | Needham | Buy | 
| 2021-01-28 | Bestätigt | H.C. Wainwright | Buy | 
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy | 
| 2020-05-11 | Fortgesetzt | Craig Hallum | Buy | 
| 2018-11-20 | Eingeleitet | H.C. Wainwright | Buy | 
                    Alle ansehen
                    
                  
                Celcuity Inc Aktie (CELC) Neueste Nachrichten
Why analysts upgrade Celcuity Inc. stockJuly 2025 Fed Impact & Free Verified High Yield Trade Plans - newser.com
Sector ETF performance correlation with Celcuity Inc.Recession Risk & Real-Time Market Trend Scan - newser.com
Key resistance and support levels for Celcuity Inc.Gold Moves & Long-Term Growth Portfolio Plans - newser.com
What institutional flow reveals about Celcuity Inc.July 2025 PreEarnings & Growth-Oriented Investment Plans - newser.com
How to track smart money flows in Celcuity Inc.July 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
ESMO 2025: Celcuity gets first positive results for Pi3K inhibitor in PiK3CA wild-type HR+/HER2 breast cancer - Yahoo Finance
Candlestick signals on Celcuity Inc. stock todayIPO Watch & Advanced Swing Trade Entry Plans - newser.com
What drives Celcuity Inc stock priceTechnical Analysis Insights & Build Diversified Portfolios With Ease - earlytimes.in
Will Celcuity Inc. stock benefit from AI adoptionVolume Spike & Daily Growth Stock Tips - newser.com
Price action breakdown for Celcuity Inc.Weekly Trend Report & AI Based Trade Execution Alerts - newser.com
How buybacks impact Celcuity Inc. stock valueTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Celcuity (CELC) Is Up 11.9% After Revealing Efficacy of Gedatolisib in ESMO Trial Results - simplywall.st
Celcuity : Corporate Presentation (Celcuity Investor Presentation V.7.1.2 Final) - MarketScreener
Celcuity (CELC) Price Target Increased by 10.74% to 84.15 - Nasdaq
When is the best time to exit Celcuity Inc.Oil Prices & Reliable Entry Point Trade Alerts - newser.com
How currency fluctuations impact Celcuity Inc. stockEarnings Beat & Technical Buy Zone Confirmation - newser.com
What analysts say about Celcuity Inc stockVolatility Trading Techniques & Grow Steadily With Our Wealth Roadmap - earlytimes.in
Published on: 2025-10-27 20:00:39 - newser.com
Finanzdaten der Celcuity Inc-Aktie (CELC)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):